Candidemia in patients with diabetes mellitus: Epidemiology and predictors of mortality

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 11-12, 2004, Pages 860-864

  Bader, Mazen S ^a,c   Lai, Sue Min ^a   Kumar, Vinutha ^b   Hinthorn, Daniel ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; FLUCONAZOLE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FUNGEMIA; FUNGUS ISOLATION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PREDICTION; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; UNITED STATES;

AGED; ANTIFUNGAL AGENTS; APACHE; CANDIDIASIS; CROSS INFECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 11344258625     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410021126     Document Type: Article

References (21)

1. Ostrosky-Zeichner L, Rex J, Bennet J, Kullberg B. Deeply invasive candidiasis. Infect Dis Clin 2002; 16: 821-35.
2. Calvet H, Yoshikawa T. Infections in diabetes. Infect Dis Clin 2001; 15: 78-100.
3. Lipovsky M, Hoepelman AM. Opportunistic fungi: candidiasis. In: Armstrong O, Cohen J, eds. Infectious diseases. London: Mosby; 2000, p. 8.26.1-2.
4. Vazquez JA, Sobel JD. Fungal infections in diabetes. Infect Dis Clin 1995; 9: 97-116.
5. Pozzilli P, Leslie R. Infection and diabetes: mechanisms and prospects for prevention. Diab Med 1994; 11: 935-41.
6. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-43.
7. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. The epidemiology of candidemia in 2 United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-70.
8. Yamamura DL, Rotstein C, Nicole LE, Loannou S. Candidemia at selected Canadian sites: results from the fungal disease registry, 1992-1994. Canadian Med Assoc J 1999; 160: 493-9.
9. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998; 20: 781-8.
10. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37: 1172-7.
11. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020-9.
12. Viscoli C, Girmenia C, Marinus L, Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the intensive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071-9.
13. Trick WE, Fridkin SK, Edwards JR, Hajjeh, Gaynes P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-30.
14. Nolla-Salas J, Stiges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor MA, Ibanez-Lucia P, Torres-Rodriguez JM. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997; 23: 23-30.
15. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25.
16. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Micro Rev 2000; 13: 662-85.
17. Libsen J, Rodriguez-Adrian, King RT, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections; frequency, natural history, and etiology. Medicine 2003; 82: 187-202.
18. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, et al. Candidemia in a tertiary care cancer center; in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine 2003; 82: 309-21.
19. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233: 542-8.
20. Gore D, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 540-4.
21. Hostetter MK. Handicaps to host defense, effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990; 39: 271-5.